Nov 06 2023
Jazz DUET Study
h in Clinical Trial
The DUET Study will evaluate daytime and nighttime effects of XYWAV® (low-sodium oxybate oral solution), also known as JZP258, in people with idiopathic hypersomnia (IH) or narcolepsy (Type 1 or Type 2).
Interested in Participating?
To learn more about the DUET Study contact:
Clinical Trial Disclosure and Transparency
Additional study information is available at www.clinicaltrials.gov using the identifier NCT05875974
The full brochure can be found here